Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

³ú·® ÀýÁ¦¼ú(Corpus Callosotomy)À» ½ÃÇà ¹ÞÀº ¼Ò¾Æ ³­Ä¡¼º °£Áú ȯ¾Æ¿¡ ´ëÇÑ È¿°ú ¹× ¿¹ÈÄ¿¡ °üÇÑ ºÐ¼® Corpus Callosotomy for Intractable Epilepsy in Children£ºSeizure Outcome and Prognostic Factors

´ëÇÑ°£ÁúÇÐȸÁö 2001³â 5±Ç 1È£ p.52 ~ 58
±è°æ¹Î, ±è´ö¼ö, °íżº, ÀÌÁ¤±³, ±èÁ¤È£,
¼Ò¼Ó »ó¼¼Á¤º¸
±è°æ¹Î ( Kim Kyung-Min ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç

±è´ö¼ö ( Kim Deok-Soo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
°íżº ( Ko Tae-Sung ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
ÀÌÁ¤±³ ( Lee Jung-Kyo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ½Å°æ¿Ü°úÇб³½Ç
±èÁ¤È£ ( Kim Jung-Ho ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ °­¸ª¾Æ»êº´¿ø ¼Ò¾Æ°ú

Abstract

¸ñÀû: ³­Ä¡¼º °£Áú ȯ¾Æ µéÀÇ Ä¡·á¿¡ ³ú·® ÀýÁ¦¼úÀÌ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Ù´Â »ç½ÇÀº °ú°ÅºÎÅÍ ¾Ë·ÁÁ® ¿ÔÀ¸³ª, ¾ÆÁ÷ ¼ö¼ú¿©ºÎ¿Í ¿¹Èĸ¦ Á¤È®ÇÏ°Ô ÆÇ´ÜÇϱâ À§ÇÑ ¿©·¯ °¡Áö ÀÎÀÚ¿¡ ´ëÇÑ ¿¬±¸´Â Á» ´õ ÁøÇàµÇ¾î¾ß ÇÑ´Ù. ÀúÀÚµéÀº ³ú·® ÀýÁ¦¼úÀ» ½ÃÇàÇÑ 20¸íÀÇ È¯¾Æ µéÀ» ´ë»óÀ¸·Î ¼ö¼ú ÀüÈÄÀÇ °æ·ÃÀÇ Çüųª ºóµµ, °³°³ÀÎÀÇ Æ¯¼º µîÀ» ºñ±³, ºÐ¼®ÇÏ¿© ³­Ä¡¼º ¼Ò¾Æ °£Áú ȯ¾Æ¿¡°Ô ½ÃÇàÇÑ ³ú·® ÀýÁ¦¼úÀÇ È¿°ú ¹× °¢°¢ÀÇ °³Àο¡ µû¸¥ ¿¹ÈÄÀÇ Â÷ÀÌ µîÀ» È®ÀÎÇÏ°íÀÚ ÇÏ¿´´Ù.

¹æ¹ý: ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°ú¿¡¼­ Ä¡·á¹Þ´ø ³­Ä¡¼º °£Áúȯ¾Æµé Áß, 1996³â 3¿ùºÎÅÍ 2000³â 4¿ù±îÁö ³ú·® ÀýÁ¦¼úÀ» ½ÃÇà ¹ÞÀº 20¸íÀÇ È¯¾Æ µéÀ» ÈÄÇâÀûÀ¸·Î °ËÅäÇÏ¿´À¸¸ç, °¢ ȯ¾ÆÀÇ °æ·ÃÀÇ ºóµµ, ¼ö¼ú¹æ¹ý, °æ·ÃÀÇ Á¾·ù, Ç× °æ·ÃÁ¦, ³úÀÇ ±¸Á¶Àû º´º¯ À¯¹« µîÀ» ºÐ¼®ÇÏ¿´´Ù.

°á°ú: ¸¶Áö¸· ÃßÀû°üÂûÀ» ±âÁØÀ¸·Î ¼ö¼ú Àü°ú ºñ±³ÇØ º¸¸é, 12¸íÀÇ È¯¾Æ°¡ ¼ö¼ú Àü¿¡ ºñÇØ 90%ÀÌ»ó ¹ßÀÛȽ¼ö°¨¼Ò¸¦ º¸¿´°í, ÀÌÁß 4¸íÀº ¼ö¼ú ÈÄ °æ·ÃÀÌ ¿ÏÀüÈ÷ ¾ø´Â »óÅÂÀ̸ç, 15¸íÀÇ È¯¾Æ°¡ ¼ö¼ú Àü¿¡ ºñÇØ 50%ÀÌ»ó ¹ßÀÛȽ¼ö°¡ °¨¼ÒÇÏ¿´´Ù. 2¸íÀÌ ¼ö¼ú ÀüÈÄ¿¡ °æ·ÃȽ¼öÀÇ º°´Ù¸¥ Â÷ÀÌ°¡ ¾ø¾úÀ¸³ª, ÀÌ Áß ÇÑ ¸íÀº ¼ö¼ú ÈÄ¿¡ È°µ¿¼ºÀÌ ¸¹ÀÌ È£ÀüµÇ¾ú´Ù. Æò±Õ °æ·Ã ½ÃÀÛ¿¬·É, °æ·Ã±â°£, ³úÀÇ ±¸Á¶Àû º´º¯ À¯¹«, ¼ö¼ú´ç½ÃÀÇ È¯¾ÆÀÇ ³ªÀÌ´Â ¼ö¼úÀÇ È¿°ú¿Í º°´Ù¸¥ ¿¬°ü¼ºÀÌ ¾ø¾ú°í, °æ·ÃÇüź°·Î´Â Á¶±Ý¾¿ Â÷ÀÌ°¡ À־ ÀûÇϹßÀÛÀÌ ¹ßÀÛȽ¼ö°¡ °¡Àå ¸¹ÀÌ °¨¼ÒÇÏ¿´°í, ±âŸ Àü½Å °­Á÷-°£´ë¼º ¹ßÀÛ, °£´ë¼º ±Ù°æ·Ã¼º ¹ßÀÛ, º¹ÇÕ ºÎºÐ¹ßÀÛ ¼øÀ¸·Î °¨¼ÒÇÏ¿´´Ù.

°á·Ð: ³­Ä¡¼º ¼Ò¾Æ °æ·Ãȯ¾Æ¿¡°Ô ½ÃÇàÇÑ ³ú·® ÀýÁ¦¼úÀº À̵鿡°Ô ¹ßÀÛȽ¼ö°¨¼Ò¿Í Àü¹ÝÀûÀÎ È°µ¿¼ºÀÇ È£ÀüÀ» °¡Á®¿Ô´Ù. ±×·¯¹Ç·Î ±¹¼ÒÀûÀÎ °£Áúº´¼Ò ÀýÁ¦°¡ ºÒ°¡´ÉÇÑ ³­Ä¡¼º ¼Ò¾Æ °æ·Ãȯ¾Æµé¿¡°Ô ³ú·® ÀýÁ¦¼úÀº Áß¿äÇÏ°Ô °í·ÁµÇ¾î¾ß ÇÒ Ä¡·á¹æ¹ýÀ̸ç, ÇâÈÄ ÀÌÀÇ È¿°ú ¹× ¿¹ÈÄ ¿¹ÃøÀÎÀÚ¿¡ ´ëÇؼ­ Áö¼ÓÀûÀ¸·Î ¿¬±¸µÇ¾î¾ß ÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.

Purpose: The therapeutic effectiveness of callosotomy in controlling medically intractable epilepsy has been discussed since first case reported. Nevertheless, patient selection, type of seizures and epileptic syndromes are now better determined. We reviewed the outcome of corpus callosotomy in 20 pediatric patients and tried to identify factors associated with good outcome.

Methods: The medical records of all pediatric patients who underwent corpus callosotomy at Asan medical center between 1996 and 2000 were retrospectively analyzed.

Results: At the time of last follow-up, four patients(20%) became seizure free, fifteen patients(75%) had significant improvement in seizure control, and two patients(10%) remained unchanged. No significant association was found between seizure outcome and age at operation, or duration of seizure, intracranial pathology, or extent of callosal section. Drop attacks are most likely to be benefited by callosotomy in view of the frequency of seizure. This was followed by generalized tonic-clonic and myoclonic seizures. Complex partial seizures had the worst response.

Conclusions: Corpus callosotomy is valuable for controlling medically intractable generalized seizures in appropriate patients. Overall, drop attacks were one of the most frequent seizure pattern and they were also most likely to be benefited from corpus callosotomy. Though most patients do not become seizure-free after corpus callosotomy, worthwhile palliation of an otherwise intractable illness can be achieved. An analysis of prognostic factors should lead to better selection of patients for surgery.

Å°¿öµå

³ú·® ÀýÁ¦¼ú; ¼Ò¾Æ ³­Ä¡¼º °£Áú
Corpus callosotomy; Intractable epilepsy in children; Seizure outcome

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS